ICLR – icon plc - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ICLR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/2

07:15 am

iclr

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Low Report

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Report

11/27

06:18 am

iclr

Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Low Report

Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Report

11/26

02:09 pm

iclr

Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/24

08:32 pm

iclr

FMI Global Equity Q3 2025 Commentary [Seeking Alpha]

Medium Report

FMI Global Equity Q3 2025 Commentary [Seeking Alpha]

Report

11/21

07:04 pm

iclr

Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]

Low Report

Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]

Report

11/14

04:43 pm

iclr

ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]

Medium Report

ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]

Report

11/13

08:11 am

iclr

Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.

Low Report

Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.

Report

11/12

07:13 am

iclr

ICON plc to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]

Neutral Report

ICON plc to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]

Report

11/12

06:45 am

iclr

ICON plc to Present at the Jefferies London Healthcare Conference

Neutral Report

ICON plc to Present at the Jefferies London Healthcare Conference

Report

10/24

12:57 pm

iclr

Icon (NASDAQ:ICLR) had its price target lowered by analysts at TD Cowen from $183.00 to $172.00. They now have a "hold" rating on the stock.

Low Report

Icon (NASDAQ:ICLR) had its price target lowered by analysts at TD Cowen from $183.00 to $172.00. They now have a "hold" rating on the stock.

Report

10/24

10:12 am

iclr

Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at Cowen Inc.

Low Report

Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at Cowen Inc.

Report

10/24

10:11 am

iclr

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Robert W. Baird.

Low Report

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Robert W. Baird.

Report

10/24

10:11 am

iclr

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at UBS Group AG.

Low Report

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at UBS Group AG.

Report

10/24

10:05 am

iclr

Icon (NASDAQ:ICLR) had its price target lowered by analysts at Barclays PLC from $190.00 to $185.00. They now have an "equal weight" rating on the stock.

Low Report

Icon (NASDAQ:ICLR) had its price target lowered by analysts at Barclays PLC from $190.00 to $185.00. They now have an "equal weight" rating on the stock.

Report

10/23

07:00 pm

iclr

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Leerink Partners.

Low Report

Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Leerink Partners.

Report

10/22

04:46 pm

iclr

ICON Reports Third Quarter 2025 Results [Yahoo! Finance]

Low Report

ICON Reports Third Quarter 2025 Results [Yahoo! Finance]

Report

10/22

04:25 pm

iclr

ICON Reports Third Quarter 2025 Results

Medium Report

ICON Reports Third Quarter 2025 Results

Report

10/8

12:25 pm

iclr

Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Report

10/8

08:51 am

iclr

ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]

Low Report

ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]

Report

10/2

09:12 am

iclr

Icon (NASDAQ:ICLR) was given a new $190.00 price target on by analysts at Barclays PLC.

Low Report

Icon (NASDAQ:ICLR) was given a new $190.00 price target on by analysts at Barclays PLC.

Report

10/2

08:22 am

iclr

[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]

Low Report

Report

9/26

09:10 am

iclr

ICON Public Limited Company (ICLR) Fell Due to Weak Results and an Uncertain Outlook [Yahoo! Finance]

Low Report

ICON Public Limited Company (ICLR) Fell Due to Weak Results and an Uncertain Outlook [Yahoo! Finance]

Report

9/24

10:52 am

iclr

Pharmacovigilance Outsourcing Market Size Worth USD 12.12 Billion by 2034 Driven by Rising Clinical Trials and Stringent Regulations [Yahoo! Finance]

Low Report

Pharmacovigilance Outsourcing Market Size Worth USD 12.12 Billion by 2034 Driven by Rising Clinical Trials and Stringent Regulations [Yahoo! Finance]

Report

9/24

09:00 am

iclr

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

Low Report

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

Report

9/22

08:44 am

iclr

Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]

Low Report

Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.